A European Organisation for Research and Treatment of Cancer randomized, double-blind, placebo-controlled, multicentre phase II trial of anastrozole in combination with gefitinib or placebo in hormone receptor-positive advanced breast cancer (NCT00066378)

Nom du journal : Eur J Cancer

Année : 2015

Volume : 53

Page de départ : 144

Page de fin : 154

Auteurs: Tryfonidis K, Basaran G, Bogaerts J, Debled M, Dirix L, Thery JC, Tjan-Heijnen VC, Van den Weyngaert D, Cufer T, Piccart M, Cameron D, on behalf of the EORTC Breast Cancer Group, on behalf of the EORTC Breast Cancer Group,